Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ames

Showing results (311-320 of 416) with videos related to

Pageof 42
Sort By:
Cancer Research|March 1, 1993
Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusionS M Blaney, F M Balis, D E Cole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Phase I study of temozolomide in children and adolescents with recurrent solid tumors: a report from the Children's Cancer GroupH S Nicholson, M Krailo, M M Ames, et al.
Glia|May 15, 2021
Elevated fibroblast growth factor-inducible 14 expression transforms proneural-like gliomas into more aggressive and lethal brain cancerNina P Connolly, Rebeca Galisteo, Su Xu, et al.
The Oncologist|January 26, 2019
A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)Thorvardur R Halfdanarson, Nathan R Foster, George P Kim, et al.
Leukemia & Lymphoma|December 17, 2002
Phase I study of gemcitabine (difluorodeoxycytidine) in children with relapsed or refractory leukemia (CCG-0955): a report from the Children's Cancer GroupP G Steinherz, N L Seibel, M M Ames, et al.
Molecular Pharmacology|May 30, 2008
Overcoming S-phase checkpoint-mediated resistance: sequence-dependent synergy of gemcitabine and 7-ethyl-10-hydroxycamptothecin (SN-38) in human carcinoma cell linesMarina Gálvez-Peralta, Nga T Dai, David A Loegering, et al.
Human Molecular Genetics|January 11, 2005
CECR2, a protein involved in neurulation, forms a novel chromatin remodeling complex with SNF2LGraham S Banting, Orr Barak, Tanya M Ames, et al.
Pediatric Blood & Cancer|January 6, 2010
Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: a Children's Oncology Group phase I consortium studyLars M Wagner, John P Perentesis, Joel M Reid, et al.
The Journal of Physical Chemistry. B|July 31, 2015
Characterization of Oxygen Bridged Manganese Model Complexes Using Multifrequency (17)O-Hyperfine EPR Spectroscopies and Density Functional TheoryLeonid Rapatskiy, William M Ames, Montserrat Pérez-Navarro, et al.
Glia|February 27, 2021
Leveraging the replication-competent avian-like sarcoma virus/tumor virus receptor-A system for modeling human gliomasPranjali P Kanvinde, Adarsha P Malla, Nina P Connolly, et al.
Pageof 42

Showing results (311-320 of 416) with videos related to

Sort By:
Pageof 42
Cancer Research|March 1, 1993
Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusionS M Blaney, F M Balis, D E Cole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Phase I study of temozolomide in children and adolescents with recurrent solid tumors: a report from the Children's Cancer GroupH S Nicholson, M Krailo, M M Ames, et al.
Glia|May 15, 2021
Elevated fibroblast growth factor-inducible 14 expression transforms proneural-like gliomas into more aggressive and lethal brain cancerNina P Connolly, Rebeca Galisteo, Su Xu, et al.
The Oncologist|January 26, 2019
A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)Thorvardur R Halfdanarson, Nathan R Foster, George P Kim, et al.
Leukemia & Lymphoma|December 17, 2002
Phase I study of gemcitabine (difluorodeoxycytidine) in children with relapsed or refractory leukemia (CCG-0955): a report from the Children's Cancer GroupP G Steinherz, N L Seibel, M M Ames, et al.
Molecular Pharmacology|May 30, 2008
Overcoming S-phase checkpoint-mediated resistance: sequence-dependent synergy of gemcitabine and 7-ethyl-10-hydroxycamptothecin (SN-38) in human carcinoma cell linesMarina Gálvez-Peralta, Nga T Dai, David A Loegering, et al.
Human Molecular Genetics|January 11, 2005
CECR2, a protein involved in neurulation, forms a novel chromatin remodeling complex with SNF2LGraham S Banting, Orr Barak, Tanya M Ames, et al.
Pediatric Blood & Cancer|January 6, 2010
Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: a Children's Oncology Group phase I consortium studyLars M Wagner, John P Perentesis, Joel M Reid, et al.
The Journal of Physical Chemistry. B|July 31, 2015
Characterization of Oxygen Bridged Manganese Model Complexes Using Multifrequency (17)O-Hyperfine EPR Spectroscopies and Density Functional TheoryLeonid Rapatskiy, William M Ames, Montserrat Pérez-Navarro, et al.
Glia|February 27, 2021
Leveraging the replication-competent avian-like sarcoma virus/tumor virus receptor-A system for modeling human gliomasPranjali P Kanvinde, Adarsha P Malla, Nina P Connolly, et al.
Pageof 42